Similar Items: Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study
- CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage
- Pharmacological mechanisms underlying neurovascular alterations related to resistant and refractory migraine: CGRP pathways and beyond
- Sex-dependent central amygdala physiology after supradural CGRP exposure is associated with migraine-like behaviors
- Clinical and social burden of migraine in Japanese males: a cross-sectional comparison with females without menstrual migraine
- Migraine impairs the auditory protective mechanism: a potential biomarker
- From bench to bedside: relevant animal models across the migraine attack phases